We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Molina (MOH) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
The upcoming report from Molina (MOH - Free Report) is expected to reveal quarterly earnings of $3.97 per share, indicating a decline of 33.9% compared to the year-ago period. Analysts forecast revenues of $10.9 billion, representing an increase of 5.4% year over year.
The consensus EPS estimate for the quarter has undergone an upward revision of 7.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some Molina metrics that are commonly tracked and projected by analysts on Wall Street.
The average prediction of analysts places 'Revenue- Premium revenue' at $10.31 billion. The estimate indicates a change of +6.3% from the prior-year quarter.
Analysts' assessment points toward 'Revenue- Premium tax revenue' reaching $474.87 million. The estimate indicates a change of -6.5% from the prior-year quarter.
It is projected by analysts that the 'Revenue- Premium revenue- Medicare' will reach $1.48 billion. The estimate indicates a change of +8% from the prior-year quarter.
The consensus estimate for 'Revenue- Premium revenue- Medicaid' stands at $7.66 billion. The estimate suggests a change of -0.1% year over year.
Based on the collective assessment of analysts, 'MCR - Total' should arrive at 90.3%. The estimate is in contrast to the year-ago figure of 89.2%.
Analysts predict that the 'MCR - Medicare' will reach 87.0%. Compared to the current estimate, the company reported 89.6% in the same quarter of the previous year.
Analysts expect 'MCR - Marketplace' to come in at 84.7%. The estimate is in contrast to the year-ago figure of 73.0%.
According to the collective judgment of analysts, 'Ending Membership by Program - Total' should come in at 5.74 million. The estimate compares to the year-ago value of 5.60 million.
Analysts forecast 'Ending Membership by Program - Medicaid' to reach 4.80 million. The estimate is in contrast to the year-ago figure of 4.94 million.
The combined assessment of analysts suggests that 'Ending Membership by Program - Medicare' will likely reach 263.02 thousand. The estimate is in contrast to the year-ago figure of 247.00 thousand.
The collective assessment of analysts points to an estimated 'Ending Membership by Program - Marketplaces' of 659.47 thousand. The estimate compares to the year-ago value of 410.00 thousand.
The consensus among analysts is that 'MCR - Medicaid' will reach 91.7%. Compared to the present estimate, the company reported 90.5% in the same quarter last year.
Shares of Molina have demonstrated returns of +8.6% over the past month compared to the Zacks S&P 500 composite's +1.2% change. With a Zacks Rank #5 (Strong Sell), MOH is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Molina (MOH) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
The upcoming report from Molina (MOH - Free Report) is expected to reveal quarterly earnings of $3.97 per share, indicating a decline of 33.9% compared to the year-ago period. Analysts forecast revenues of $10.9 billion, representing an increase of 5.4% year over year.
The consensus EPS estimate for the quarter has undergone an upward revision of 7.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some Molina metrics that are commonly tracked and projected by analysts on Wall Street.
The average prediction of analysts places 'Revenue- Premium revenue' at $10.31 billion. The estimate indicates a change of +6.3% from the prior-year quarter.
Analysts' assessment points toward 'Revenue- Premium tax revenue' reaching $474.87 million. The estimate indicates a change of -6.5% from the prior-year quarter.
It is projected by analysts that the 'Revenue- Premium revenue- Medicare' will reach $1.48 billion. The estimate indicates a change of +8% from the prior-year quarter.
The consensus estimate for 'Revenue- Premium revenue- Medicaid' stands at $7.66 billion. The estimate suggests a change of -0.1% year over year.
Based on the collective assessment of analysts, 'MCR - Total' should arrive at 90.3%. The estimate is in contrast to the year-ago figure of 89.2%.
Analysts predict that the 'MCR - Medicare' will reach 87.0%. Compared to the current estimate, the company reported 89.6% in the same quarter of the previous year.
Analysts expect 'MCR - Marketplace' to come in at 84.7%. The estimate is in contrast to the year-ago figure of 73.0%.
According to the collective judgment of analysts, 'Ending Membership by Program - Total' should come in at 5.74 million. The estimate compares to the year-ago value of 5.60 million.
Analysts forecast 'Ending Membership by Program - Medicaid' to reach 4.80 million. The estimate is in contrast to the year-ago figure of 4.94 million.
The combined assessment of analysts suggests that 'Ending Membership by Program - Medicare' will likely reach 263.02 thousand. The estimate is in contrast to the year-ago figure of 247.00 thousand.
The collective assessment of analysts points to an estimated 'Ending Membership by Program - Marketplaces' of 659.47 thousand. The estimate compares to the year-ago value of 410.00 thousand.
The consensus among analysts is that 'MCR - Medicaid' will reach 91.7%. Compared to the present estimate, the company reported 90.5% in the same quarter last year.
View all Key Company Metrics for Molina here>>>Shares of Molina have demonstrated returns of +8.6% over the past month compared to the Zacks S&P 500 composite's +1.2% change. With a Zacks Rank #5 (Strong Sell), MOH is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .